The Magazine of Chemistry Europe

Nuclear imaging techniques study the brain distribution of multiple sclerosis drugs with additional iodine

The number of effective anti-tuberculosis (TB) drugs continues to dwindle; can we find new agents for treating drug-resistant TB?

HIV-1 integrase (IN) is an essential enzyme for HIV-1 replication: New routes to IN inhibition could overcome drug resistance

The importance of an often overlooked source of chirality, atropisomerism, depends upon the barriers to rotation

1985 was an important year in the history of HIV/AIDS research: a look at the past and future of HIV research

Single drug that blocks NO production by inhibiting two different enzyme targets could reduce tumor growth

Asborin, the carbaborane-containing analogue of aspirin, holds promise as lead structure for aldo/keto reductase (AKR) inhibition

Delivery of tubulysin analogues using dendrimer conjugation technology promises efficacy without toxicity

A proteomics approach to protein binding provides a pull-down menu for medicinal chemists

Extremely potent compound against various multidrug-resistant HIV-1 variants developed